drug
nebivolol hydrochloride
Marketedupdated 3mo agoby Beximco Pharmaceuticals USA Inc
Approvedcommunity read0 votes
indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 29, 2026
9 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Oct 4, 2027method-of-use (U-185)US 78385521.1y
- Aug 29, 2026formulationUS 78038389d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that